CDDF Diversity Initiative: In-Person Meeting in Brussels Today
Following several work package meetings over the past 10 months, the final project meeting for the Diversity Initiative is in full swing in Brussels. Our multi-stakeholder working group members and experts have gathered to advance their work on developing and...
![[EMA News] Public Consultation: Concept Paper on Guideline Revision on Good Pharmacogenomic Practice](https://cddf.org/wp-content/uploads/2026/03/EMA-News-400x250.jpg)
[EMA News] Public Consultation: Concept Paper on Guideline Revision on Good Pharmacogenomic Practice
🔔📢The European Medicines Agency has published for public consultation: a Concept paper on the guideline revision on good pharmacogenomic practice. Since its initial publication in 2018, the guideline on good pharmacogenomic practice has played a crucial role in...
Multi-stakeholder Interview: Get an Inside Look at the CDDF Annual Conference 2026
We are excited to share interview clips featuring a diverse group of stakeholders at this year’s CDDF annual conference. Held in Ghent on 9-11 February, the meeting highlighted multi-stakeholder collaboration as the cornerstone of our shared mission to improve cancer...
Executive Summary: CDDF Annual Conference 2026 – “Cancer Clinical Research in a Changing Global Environment” (9-11 Feb 2026)
The Cancer Drug Development Forum (CDDF) is delighted to announced that the executive summary of this year’s Annual Conference has been published today and is available to all our stakeholders. This multi-stakeholder conference took place on 9-11 February 2026 in...
ACT EU: MSP AG – Call for Expressions of Interest
📢 🔔Take a look at the below 'Call for Expressions of Interest' from the Multi-stakeholder Platform Advisory Group (MSP AG) under ACT EU: ▶️ Message from ACT EU: MSP AG "Call for Expression of Interest – Focus Group on the review of the Guideline for the notification...
![[NEW PUBLICATION: WHITE PAPER – Innovative Oncology Trial Designs: Time to Act]](https://cddf.org/wp-content/uploads/2026/02/202602_INNOVATIVE-ONCOLOGY-TRIAL-DESIGNS_TIME-TO-ACT-400x250.jpg)
[NEW PUBLICATION: WHITE PAPER – Innovative Oncology Trial Designs: Time to Act]
While the CDDF Annual Conference 2026 is in full swing, we are thrilled to announce the publication of our latest white paper: “Innovative oncology trial designs: Time to act – A review with recommendations of the Cancer Drug Development Forum.” This paper was largely...
Key Takeaways of the CDDF ACT-EU Webinar Series
The Cancer Drug Development Forum (CDDF) is pleased to share the key takeaways from our recent ACT-EU webinar series, “Collaborating with stakeholders to define priorities for clinical trials and working collectively to address them.” The first session was held on 15...
Key Takeaways of the CDDF Webinar : “Long-Term Outcomes of In-Utero Exposure to Cytotoxic Therapy.”
The Cancer Drug Development Forum (CDDF) is pleased to share the key takeaways from our recent webinar, "Long-term outcomes of in-utero exposure to cytotoxic therapy." This webinar was held on 4 December 2025 and featured insightful presentations from speakers Agnes...
Executive Summary: Multi-Stakeholder Workshop on “Enabling Smarter Clinical Trials to Optimise Patient Care” (17-18 Nov 2025)
The Cancer Drug Development Forum (CDDF) is delighted to announce that the executive summary of its latest multi-stakeholder workshop, "Enabling Smarter Clinical Trials to Optimise Patient Care," has been published today and is available to all our stakeholders. The...